Anxiety and depression status in patients with idiopathic pulmonary fibrosis and outcomes of nintedanib treatment: an observational study

CONCLUSION: Anxiety and depression in IPF patients are closely related to somatic symptoms, pulmonary function, and quality of life. The SGRQ-T score is of great value for assessing anxiety and depression in patients with IPF. Short-term treatment with nintedanib antifibrotic therapy can alleviate anxiety and depression in IPF patients.PMID:38581666 | PMC:PMC11000612 | DOI:10.1080/07853890.2024.2323097

Source: Annals of Medicine - April 6, 2024 Category: Internal Medicine Authors: Xing He Jiaqi Ji Zongmin Pei Zeli Luo Siyu Fang Xiaoqin Liu Yan Lei Haiying Yan Lu Guo Source Type: research